SEDANA Sedana Medical AB (publ)

STO · SE · Healthcare · Medical Devices · sedanamedical.com

9.730SEK+2.10%Mkt Cap: 92.45M $P/E: —3d ago

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Spain, Germany, and internationally. The company offers Sedaconda A…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.60BUSDP/E 18.7

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

Key Statistics

Company

Market Cap92.45M USD

Enterprise Value86.30M USD

Revenue (TTM)18.70M USD

Gross Profit13.65M USD

Net Income (TTM)-5.67M USD

Revenue/Share1.97 SEK

Last Price9.730 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees117

CountrySE

SectorHealthcare

IndustryMedical Devices

ISINSE0015988373

Valuation

P/E (Trailing)—

P/E (Forward)-56.06

PEG—

EV/EBITDA-33.84

EV/Revenue4.62

P/S4.84

P/B1.07

EPS (TTM)-0.36

EPS (Forward)-0.17

52W Range

7.90030% of range13.92

52W High13.92 SEK

52W Low7.900 SEK

Profitability

Gross Margin71.27%

Oper. Margin-20.49%

EBITDA Margin-13.64%

Profit Margin-29.59%

ROE-6.58%

ROA-6.21%

Growth

Revenue Growth-1.40%

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.22M USD

CapEx (TTM)5.97M USD

FCF Margin-26.70%

FCF Yield-5.40%

Net Debt-4.25M USD

Net Debt/EBITDA1.67

Balance Sheet

Debt/Equity0.01

Current Ratio2.89

Quick Ratio1.83

Book Value/Sh8.94 SEK

Cash/Share0.52 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 SEK

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split4:1

Split DateMay 26, 2021

Analyst Consensus

Rating—

Target (Mean)18.00 SEK

Upside (mean)+85.0%

Target Range18.00 SEK – 18.00 SEK

# Analysts1

Ownership

Shares Out.99.34M

Float61.93M

Insiders18.64%

Institutions46.91%

Technical

SMA 5010.57 (-7.9%)

SMA 2009.680 (+0.5%)

Beta0.80

S&P 52W Chg13.94%

Avg Vol (30d)161.13K

Avg Vol (10d)96.71K

Technical Indicators

RSI (14)44.4

MACD-0.2743

MACD Signal-0.2286

MACD Hist.-0.0457

BB Upper10.93 SEK

BB Middle10.09 SEK

BB Lower9.246 SEK

BB Width16.67%

ATR (14)0.5387 SEK

Vol Ratio (20d)1.11x